rethinkTHC Search
Menu
Study breakdown

71% of Arizona Budtenders Recommended Cannabis Products for Morning Sickness

ObservationalPreliminary evidence
The takeaway

Mystery calls to 104 Arizona dispensaries found 71% of budtenders recommended cannabis products for morning sickness, especially CBD and edibles, with only 35% proactively suggesting medical consultation.

Pregnant individuals, OB/GYN nurses and clinicians, and policymakers regulating dispensaries.

71% recommended cannabis for morning sickness, but only 35% proactively suggested seeing a doctor

What the researchers found

71.2% of budtenders recommended cannabis products for morning sickness, particularly CBD products and edibles. Some recommended inhalation products (12.2%) and tinctures (18.9%). While 85.6% eventually encouraged medical consultation, only 34.6% did so without prompting. A few (5.4%) recommended topical products.

Why it matters

Morning sickness is common and distressing, but cannabis use during pregnancy is associated with adverse outcomes. Budtenders actively recommending cannabis for morning sickness without proactively suggesting medical consultation could put pregnant consumers and their babies at risk.

The numbers in context

104 budtenders called, 67% response rate. 71.2% recommended cannabis products. Products recommended: CBD, edibles (most common), tinctures (18.9%), inhalation (12.2%), topicals (5.4%). Medical consultation: 85.6% encouraged when asked, but only 34.6% proactively.

How the study worked

Descriptive observational study using mystery calling. Two researchers called 104 Arizona dispensaries between February-April 2024, asking about morning sickness management and documenting budtender responses on standardized forms.

What this study cannot tell us

Arizona only, which may not represent other states. Mystery calling captures initial phone interactions, not in-person consultations. Cannot determine what information was communicated beyond the scripted scenario. 67% response rate means one-third of dispensaries were not reached.

How to read the evidence

Preliminary: mystery-call methodology in one state with standardized but limited interaction, capturing phone recommendations that may differ from in-person encounters.

When this study was published

2025 study (calls February-April 2024).

The bigger picture

This mirrors the broader pattern of budtenders providing health recommendations beyond their training. With prenatal cannabis use increasing and evidence of fetal harm growing, the gap between dispensary recommendations and medical evidence is particularly concerning.

Questions still open

  • Should states require pregnancy-specific warnings at dispensaries? Would mandated budtender training on pregnancy risks change recommendation patterns? How do these recommendations influence pregnant consumers' decisions?

Common questions

Is cannabis safe for morning sickness?
Evidence suggests cannabis use during pregnancy is associated with adverse outcomes including low birth weight and preterm birth. This study found most budtenders recommended it anyway, highlighting a gap between dispensary advice and medical evidence.
What products were most recommended?
CBD products and edibles were the most commonly recommended, though some budtenders suggested inhalation products like vapes and joints, which carry additional respiratory concerns during pregnancy.

Read the original research

Recommendations From Arizona Budtenders to Mystery Callers Regarding Morning Sickness.

Journal of obstetric, gynecologic, and neonatal nursing : JOGNN, 54(3), 282-287.e1

Citation

Madson, Michael J; Srivastava, Unnati; Gade, Yoshita. (2025). Recommendations From Arizona Budtenders to Mystery Callers Regarding Morning Sickness.. Journal of obstetric, gynecologic, and neonatal nursing : JOGNN, 54(3), 282-287.e1. https://doi.org/10.1016/j.jogn.2025.02.001

Explore the wider topic